Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $529.3M |
| Sales growthchange from the year before | +3.6% |
| Gross marginshare of sales left after the direct cost of what it sells | 44.0% |
| Operating marginshare of sales left after running the business | 1.1% |
| Net marginshare of sales kept as profit | 2.8% |
| Return on invested capitalprofit made on each $100 put into the business | 3.8% |
| Return on equityprofit vs. shareholders' accounting value | 11.7% |
| Change in share countnegative = the company is buying back its shares | +11.7% |
2 insiders sold $931K (all under pre-arranged plans) on the open market.
| Rothstein Amy MDirector | Sold (plan)Aug 5 | 2,100 shat $16.00 · $34K |
| Binder Kurtis JosephChief Financial Officer | Sold (plan)Aug 4 | 27,297 shat $15.52 · $424K |
| Rothstein Amy MDirector | Sold (plan)Aug 4 | 5,010 shat $15.34 · $77K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy